期刊文献+

非小细胞肺癌患者术后肺部感染与PCT、sTREM-1及hs-CRP水平的关系 被引量:5

Relationship between Pulmonary Infection and PCT,sTREM-1 and hs-CRP Levels in Patients with NSCLC
下载PDF
导出
摘要 【目的】探讨非小细胞肺癌(NSCLC)患者术后肺部感染与降钙素原(PCT)、髓样细胞触发受体(sTREM-1)及超敏C反应蛋白(hs-CRP)水平的关系。【方法】因NSCLC于本院行手术治疗并在术后出现肺部感染的37例患者设为肺部感染组,另外选择同期收治的37例术后未出现肺部感染的NSCLC患者为非肺部感染组。比较两组患者术后24h血清PCT、sTREM-1、hs-CRP水平差异,通过ROC曲线分析血清PCT、sTREM-1、hs-CRP预测NSCLC患者术后肺部感染的价值,以Logistic回归性分析PCT、sTREM-1、hs-CRP是否为NSCLC患者术后肺部感染的危险因素。【结果】肺部感染组血清PCT、sTREM-1、hs-CRP水平显著高于非肺部感染组,且差异有显著性(P<0.05)。经ROC分析PCT、sTREM-1、hs-CRP的下曲线面积分别为0.829、0.738、0.955。经Logistic回归性分析PCT>4.715、sTREM-1>4.410、hs-CRP>8.245是NSCLC患者术后肺部感染的危险因素。【结论】NSCLC术后肺部感染患者PCT、sTREM-1、hs-CRP水平呈高表达,是术后肺部感染的危险因素。 【Objective】To study the relationship between pulmonary infection and levels of procalcitonin(PCT),myeloid trigger receptor(sTREM-1)and hypersensitive C-reactive protein(hs-CRP)in patients with non-small cell lung cancer(NSCLC).【Methods】A total of 37 cases of NSCLC patients who received surgical treatment in our hospital and developed postoperative pulmonary infection were selected as the study subjects,and were set as the pulmonary infection group.In addition,37 cases of NSCLC patients who did not show postoperative pulmonary infection were set as the non-pulmonary infection group.Serum PCT,sTREM-1 and hs-CRP were detected in both groups after blood samples were collected 24h after surgery.ROC curve was used to analyze the value of serum PCT,sTREM-1 and hs-CRP in predicting postoperative pulmonary infection in NSCLC patients.Logistic regression was used to analyze whether PCT,sTREM-1 and hs-CRP were risk factors for postoperative pulmonary infection in NSCLC patients.【Results】The levels of PCT,sTREM-1 and hs-CRP in the lung infection group were significantly higher than those in the non pulmonary infection group(P<0.05).The lower curve areas of PCT,sTREM-1 and hs-CRP were 0.829,0.738 and 0.955 respectively by ROC analysis.Logistic regression analysis showed that PCT>4.715,sTREM-1>4.410,hs-CRP>8.245 were risk factors of postoperative pulmonary infection in NSCLC patients.【Conclusion】The high expression of PCT,sTREM-1 and hs-CRP in NSCLC patients with postoperative pulmonary infection is a risk factor of postoperative pulmonary infection.
作者 王彩荣 于学文 WANG Cai-rong;YU Xue-wen(Department of Infectious Diseases,The First Affiliated Hospital of Xi'an Jiaotong University,Xi'an Shanxi,718500,China;不详)
出处 《医学临床研究》 CAS 2020年第12期1831-1833,共3页 Journal of Clinical Research
关键词 非小细胞肺/外科学 非小细胞肺/并发症 肺炎 降钙素/分析 C反应蛋白质/分析 Carcinoma Non-Small-Cell Lung/SU Carcinoma Non-Small-Cell Lung/CO Pneumonia Calcitonin/AN C-Reactive Protein/AN
  • 相关文献

参考文献6

二级参考文献34

  • 1Li B, Liu J, Feng R, et al. The tumor-immune index is correlated with the prognosis of patients after curative resection for nonsmall cell lung cancer[J]. Medicine (Baltimore), 2015, 94 (48): e2174. DOI: 10. 1097/MD. 0000000000002174.
  • 2BluthgenMV, Besse I3. Second-line combination therapies in nonsmall cell lung cancer without known driver mutations[J]. Eur Respir Rev, 2015, 24 (138) : 582 593. DOI: 10. 1183/16000617. 00002115.
  • 3Remon J, Gorham J, Besse B, et al. Circulating free DNA, new dynamic marker in nonsmall cell lung cancer patients[J]. Eur Respir J, 2015,46 ( 6 ) : 1548 1550. DOI: 10. 1183/13993003. 01482-2015.
  • 4Jin J, Liu BZ, Wu ZM. Evaluation of melanoma antigen gene A3 expression in drug resistance of epidermal growth factor receptotyrosine kinase inhibitors in advanced nonsmall cell lung cancer treatment [J]. J Cancer Res Ther. 2015, 11 Suppl: C271-4. 1X)I.. 10. 4103/0973 1482. 170549.
  • 5Ju Y, Hu Y, Sun S, et al. Toxicity and adverse effects of everolimus in the treatment of advanced nonsmall cell lung cancer pretreated with chemotherapy Chinese experiences [J ] . Indian J Cancer,2015, 52 Suppl: E32 E36. PA)I: 10.4103/ 0019 509X. 168954.
  • 6Yin X, Ying J, 1.i L, et al. A metaanalysis of lentinan injection combined with chemotherapy in the treatment of nonsmall cell lung cancer [J]. Indian J Cancer, 2015, 52 Suppl: E29-E31. DOI: 10. 4103/ 0019-509X. 168953.
  • 7Yoshino R, Imai H, Mori K, et al. Clinical impact of postprogression survival for overall survival in elderly patients (aged 75 years or older) with advanced nonsmall cell lung cancer[J]. J Cancer Res Ther, 2015, 11 (3): 606-611. DOI: 10.4103/0973 1482. 163683.
  • 8张晓慧,李光韬,张卓莉.C反应蛋白与超敏C反应蛋白的检测及其临床意义[J].中华临床免疫和变态反应杂志,2011,5(1):74-79. 被引量:247
  • 9张玉梅,李春姗,陈逸恒.培美曲塞单药维持化疗晚期非小细胞肺癌的疗效观察[J].实用临床医药杂志,2011,15(13):48-50. 被引量:21
  • 10吴方红.培美曲塞或吉西他滨联合顺铂治疗晚期非小细胞肺癌的比较研究[J].中国医药指南,2011,9(30):211-212. 被引量:8

共引文献308

同被引文献70

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部